Caracterización de estudios sobre calidad de vida relacionada con la salud en personas con psoriasis: Revisión sistemática 2003-2013

Background: Psoriasis is a chronic skin disease that mainly affects the adult population and negatively affects the health-related quality of life (HRQoL). Objective: To characterize the studies on HRQoL in people with psoriasis, 2003-2013. Methods: Systematic review of the literature. We applied a...

Full description

Autores:
Franco-Aguirre J.Q.
Cardona Arias, Jaiberth antonio
Tipo de recurso:
Article of journal
Fecha de publicación:
2023
Institución:
Universidad Cooperativa de Colombia
Repositorio:
Repositorio UCC
Idioma:
OAI Identifier:
oai:repository.ucc.edu.co:20.500.12494/49684
Acceso en línea:
https://doi.org/10.1016/S0121-8123(14)70145-8
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020479598&doi=10.1016%2fS0121-8123%2814%2970145-8&partnerID=40&md5=5e728e36dcde50b2d79f4d1557f27d8d
https://hdl.handle.net/20.500.12494/49684
Palabra clave:
ARTICLE
CONFIDENCE INTERVAL
DISABILITY
DISEASE SEVERITY
EUROPE
HUMAN
INFORMATION RETRIEVAL
METHODOLOGY
MORBIDITY
NORTH AMERICA
PREVALENCE
PSORIASIS
PSORIASIS VULGARIS
PUBLICATION
QUALITY CONTROL
QUALITY OF LIFE
REPRODUCIBILITY
SHORT FORM 36
SYSTEMATIC REVIEW
Rights
openAccess
License
http://purl.org/coar/access_right/c_abf2
Description
Summary:Background: Psoriasis is a chronic skin disease that mainly affects the adult population and negatively affects the health-related quality of life (HRQoL). Objective: To characterize the studies on HRQoL in people with psoriasis, 2003-2013. Methods: Systematic review of the literature. We applied a research protocol with search terms, inclusion and exclusion criteria, and quality assessment of articles, by two researchers to ensure the completeness and reproducibility. The analysis was based on proportions, absolute frequencies, and the confidence intervals for proportions. Results: The initial search identified 8684 studies, out of which 220 met the protocol established. Europe and North America accounted for the largest number of publications in HRQoL in people with psoriasis (86.4%), with 43.2% of studies seeking health profiles or HRQoL, and 46.8% to measure the impact of a therapeutic action on HRQoL. The measurement tools most used to study HRQoL in this group are the DLQI (Dermatology Life Quality Index) and SF-36. The largest proportion of studies did not show the severity state, and among the studies that did show it, the most common form was psoriasis vulgaris. Conclusion: Despite the high prevalence of psoriasis in the world, few countries have published studies of the impact on HRQoL. The results found here demonstrate the importance and the need for the implementation of valid and reliable HRQOL measurement tools that can transcend traditional measurements of morbidity and disability, particularly in countries of America, where the development of research on this topic is scarce. © 2013 Asociación Colombiana de Reumatología.